Headache & Migraine
This proof-of-concept trial provides “critical information and paves the way for subsequent placebo-controlled studies.”
Clinical Topics & News
“Triptans will be around for a long time, but the newer medications are here to stay,”
Two neurologists came to very difficult conclusions over whether opioids should be considered for headache treatment.
As many as 3% of the population may experience this visual abnormality, but it’s usually benign.
The condition may be new onset or an exacerbation an existing condition, and should raise suspicion of COVID-19 infection.
The findings suggest that erenumab may help overcome longstanding issues with migraine medication adherence.
“Future prospective studies are needed to better understand this disabling disorder.”
Participants in a new study applied neurostimulation for a continuous 2-hour period within 4 hours of a migraine attack.
But some fared better when they were stuck at home instead of at school.